|
ZNF524 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.381000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.785000E-01 |
| Normal-vs-Stage2 |
9.898200E-01 |
| Normal-vs-Stage3 |
7.817600E-01 |
| Normal-vs-Stage4 |
6.746600E-01 |
| Stage1-vs-Stage2 |
6.097800E-01 |
| Stage1-vs-Stage3 |
4.120800E-01 |
| Stage1-vs-Stage4 |
5.045600E-01 |
| Stage2-vs-Stage3 |
8.375000E-01 |
| Stage2-vs-Stage4 |
7.587400E-01 |
| Stage3-vs-Stage4 |
8.731400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.429200E-01 |
| Normal-vs-AfricanAmerican |
6.527000E-01 |
| Normal-vs-Asian |
6.807800E-01 |
| Caucasian-vs-AfricanAmerican |
7.281800E-01 |
| Caucasian-vs-Asian |
6.034400E-01 |
| AfricanAmerican-vs-Asian |
7.100600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.362600E-01 |
| Normal-vs-Female |
2.605000E-01 |
| Male-vs-Female |
1.340800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.218400E-01 |
| Normal-vs-Extreme_Weight |
2.916600E-01 |
| Normal-vs-Obese |
9.250800E-01 |
| Normal-vs-Extreme_Obese |
7.443800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.391600E-01 |
| Normal_Weight-vs-Obese |
3.753400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.133800E-01 |
| Extreme_Weight-vs-Obese |
2.412800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.921000E-01 |
| Obese-vs-Extreme_Obese |
7.306600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.577200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.857800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.897800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.314800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.251600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.322000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.520600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.233400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.200000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.214600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.307000E-01 |
| Normal-VS-Type2 PRCC |
4.752200E-01 |
| Normal-VS-KIRP CIMP |
7.100000E-01 |
| Normal-VS-Unclassified PRCC |
7.638200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.279900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.148600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.204000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.307200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.997800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.436600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.790000E-01 |
| Normal-vs-N1 |
4.150200E-01 |
| Normal-vs-N2 |
5.249000E-01 |
| N0-vs-N1 |
1.496970E-01 |
| N0-vs-N2 |
8.860400E-01 |
| N1-vs-N2 |
4.270400E-01 |
|
|
